Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the first quarter of 2025.
In this edition, two UK actions fail to clear a low bar, a movie isn’t a video, and spam isn’t free. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more. This edition’s video features recent trends in class action and multidistrict litigation involving PFAS.
We wrap up the Roundup with a summary of class action settlements finalized in the first quarter.
Class Action & MDL Roundup
June 24, 2025
Class Action & MDL Roundup | 2025 Q1 – Our terms define class
-
Cari K. Dawson
-
Madeleine Juszynski Davidson
-
Matthew D. Lawson
-
David Venderbush
-
Jamie S. George
-
Sarah O’Donohue
-
Ryan P. Ethridge
-
Bradley Harder
-
Chandler McCrary Ray
-
Emma Braden
-
Sheena Hilton
-
Gavin Reinke
- James Brehaut-Elms
-
William Hooker
-
Andrew A. Roberts
-
Nick Brocklesby
-
Kara F. Kennedy
-
Jason Rottner
-
Samantha Burdick
-
Alex Shattock
-
Gillian H. Clow
-
Kate Kostel
-
Troy A. Stram
-
Jyoti Jindal Kottamasu
-
Andrew T. Sumner
-
Sean R. Crain
-
John Evan Laughter
-
Nick A. Young
Related News & Insights
-
Class Action & MDL Roundup March 26, 2025Class Action & MDL Roundup | 2024 Q4 – We give you the benefit of the bargainIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2024, an overdue audiobook suit is shelved, an old case gets new reps and new evidence, and face-swappers get SLAPPed. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup July 2, 2024Class Action & MDL Roundup 2024 Q1 – Reaching across the pondIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2024, UK High Court weighs in on information asymmetry, debit is better than credit, and it helps to have a credible plaintiff. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup September 29, 2023Class Action & MDL Roundup 2023 Q2 – Ascertainability lives!In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2023, essential oils may need therapy, an ever-growing library goes nowhere, and one exclusion is specifically ambiguous. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup June 30, 2023Class Action & MDL Roundup 2023 Q1 – We don’t discount confidentialityIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2023, in pork we antitrust, paid time off is not pay, and if it’s free, it won’t cost you a TCPA violation. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup March 27, 2023Class Action & MDL Roundup 2022 Q4 – A “healthy” dose of litigationIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2022, class actions gain an international flair, insurers have cures for COVID cases, and a remote presence is still a presence. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Media Contact